IRIS
VAGO, LUCA ALDO EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.248
NA - Nord America 2.130
EU - Europa 1.930
SA - Sud America 1.481
AF - Africa 89
OC - Oceania 12
Totale 9.890
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.018
SG - Singapore 1.670
BR - Brasile 1.243
CN - Cina 1.108
HK - Hong Kong 691
SE - Svezia 635
IT - Italia 504
VN - Vietnam 420
RU - Federazione Russa 219
DE - Germania 182
AR - Argentina 91
GB - Regno Unito 79
FI - Finlandia 70
JP - Giappone 59
AT - Austria 56
IN - India 56
EC - Ecuador 52
NL - Olanda 46
CA - Canada 44
BD - Bangladesh 39
ID - Indonesia 39
MX - Messico 38
ZA - Sudafrica 31
CO - Colombia 28
IQ - Iraq 27
PL - Polonia 26
PY - Paraguay 24
PK - Pakistan 22
FR - Francia 21
TR - Turchia 20
UZ - Uzbekistan 18
IE - Irlanda 17
SA - Arabia Saudita 15
VE - Venezuela 14
CL - Cile 13
ES - Italia 13
TN - Tunisia 13
AU - Australia 12
IR - Iran 12
MA - Marocco 12
DZ - Algeria 11
HU - Ungheria 10
EG - Egitto 9
UA - Ucraina 9
KE - Kenya 8
PE - Perù 8
HN - Honduras 7
JM - Giamaica 7
CH - Svizzera 6
LT - Lituania 6
UY - Uruguay 6
IL - Israele 5
KW - Kuwait 5
KZ - Kazakistan 5
LB - Libano 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BE - Belgio 4
RS - Serbia 4
CZ - Repubblica Ceca 3
GE - Georgia 3
JO - Giordania 3
NI - Nicaragua 3
NP - Nepal 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
GR - Grecia 2
GT - Guatemala 2
MD - Moldavia 2
MY - Malesia 2
PA - Panama 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
BW - Botswana 1
CY - Cipro 1
ET - Etiopia 1
GD - Grenada 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 9.890
Salva come PNG Salva come JPEG
Città #
Singapore 731
Hong Kong 623
Dallas 377
Shanghai 315
Hefei 252
Lawrence 225
Princeton 225
Ashburn 222
Milan 176
Ho Chi Minh City 162
Beijing 147
São Paulo 124
New York 95
Hanoi 79
Moscow 73
Nuremberg 58
Los Angeles 51
Helsinki 43
Boardman 35
Rio de Janeiro 32
Tokyo 30
Munich 29
Brasília 27
Vienna 26
Denver 25
Belo Horizonte 24
Cesano Boscone 21
Montreal 20
Quito 20
Warsaw 20
Brooklyn 19
Guangzhou 19
Guayaquil 19
Curitiba 18
Johannesburg 18
Stockholm 18
Da Nang 17
Dublin 17
Haiphong 17
Poplar 17
Rome 17
Tashkent 16
Turku 16
Atlanta 14
Bergamo 13
Salvador 13
Tianjin 13
Campinas 12
Manchester 12
Porto Alegre 12
Santa Clara 12
Caxias do Sul 11
Chennai 11
Lappeenranta 11
Mexico City 11
Seattle 11
Washington 11
Ankara 10
Bologna 10
Bolzano 10
Chaoyang 10
Hangzhou 10
London 10
Nova Iguaçu 10
Recife 10
San Francisco 10
Shenzhen 10
Shijiazhuang 10
Toronto 10
Amsterdam 9
Baghdad 9
Chicago 9
Duque de Caxias 9
Guarulhos 9
Reston 9
São Gonçalo 9
Uberlândia 9
Aracaju 8
Biên Hòa 8
Bogotá 8
Budapest 8
Fortaleza 8
Houston 8
Hải Dương 8
Montes Claros 8
Naples 8
Orem 8
Santo André 8
Segrate 8
Thái Bình 8
Thái Nguyên 8
Turin 8
Uberaba 8
Brescia 7
Buenos Aires 7
Franca 7
Gorgonzola 7
Kingston 7
Lima 7
Lomas de Zamora 7
Totale 5.051
Salva come PNG Salva come JPEG
Nome #
Loss of mismatched HLA in leukemia after stem-cell transplantation 133
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 131
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 123
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 111
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 106
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 102
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 102
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 97
MODELING ADOPTIVE IMMUNOTHERAPY IN MOUSE-HUMANS CHIMERAS TO IDENTIFY NOVEL MECHANISMS OF LEUKEMIA IMMUNOEDITING 95
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 94
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 82
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 80
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 79
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 77
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 77
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 75
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes 72
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 70
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 70
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse 68
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 65
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 65
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 64
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 64
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 63
Alterations in the genomic and transcriptional profile of leukemia upon the immune pressure of allogenic hematopoietic stem cell transplantation: tracking immunoediting by high-throughput techniques 63
Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation 63
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody 62
Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma 61
Anidulafungin primary antifungal prophylaxis in 36 high-risk haematological patients undergoing haematopoietic stem cell transplantation 61
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 60
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 58
QUANTITATIVE PCR-BASED CHIMERISM MONITORING IN BONE MARROW OR PERIPHERAL BLOOD TO PREDICT LEUKAEMIA RELAPSE IN HIGH-RISK PATIENTS: FINAL RESULTS OF THE KIM-PB PROSPECTIVE STUDY 58
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 57
Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 57
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 56
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 55
An Accelerated CD8+, but Not CD4+, T -Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 55
Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease 55
An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 55
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation 55
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 54
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse 54
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 54
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 54
Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience 53
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 52
ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES: 4GY TBI TO INTENSIFY TREOSULFAN AND FLUDARABINE-BASED CONDITIONING 52
AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT 52
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in Italy 52
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 50
Targeting WT1 reactivation in patients in complete remission after allogeneic haematopoietic stem cell transplantation for AML and MDS: results in 111 patients 50
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti 50
The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia 49
Allogeneic haematopoietic stem cell transplantation in patients older than 65 years with high risk acute myeloid leukemia: results in 46 consecutive patients 49
SUICIDE GENE TRANSFER INTO DONOR LYMPHOCYTES ALLOWS EARLY AND EFFECTIVE IMMUNE-RECONSTITUTION AFTER FAMILY HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIAS: RESULTS OF THE TK007 STUDY 48
The effect of donor-recipient KIR ligand incompatibility after haploidentical hematopoietic stem cell transplantation is overruled by biological characteristics of early reconstituting NK cells with impaired graft versus leukemia activity 48
Experts' considerations on HLA-haploidentical stem cell transplantation 47
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 47
TREOSULFAN-BASED CONDITIONING AND UNMANIPULATED PERIPHERAL BLOOD HAPLOIDENTICAL TRANSPLANTATION (HAPLOSCT) FOR PRIMARY REFRACTORY AND RELAPSED AML: RESULTS IN 63 PATIENTS 47
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 47
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 47
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 46
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 46
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 45
Timing and rate of success in transplant of MUD searches through BMDW: the real case of CIC-813 in 2006–2009 45
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells 45
Tracking genetically engineered lymphocytes long-term reveals the dynamic of T-cell immunological memory 45
Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia 44
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report 43
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party 43
Improving the safety of cell therapy with the TK-suicide gene. 43
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors 43
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 43
Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation 42
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 42
MRD in Venetoclax-Based Treatment for AML: Does it Really Matter? 41
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 41
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 41
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 41
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome 41
Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors 41
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 41
Early post-allogeneic transplantation WT1 transcript positivity predicts AML relapse 41
Long-term immunological profile of patients treated with haploidentical HSCT and TK-cells to unravel the requirements of memory T cell persistence 41
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: Dynamics and clinical implications 40
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 40
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 40
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 40
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells 39
Immune escape and immunotherapy of acute myeloid leukemia 39
DAY-14 LAIP ON BONE MARROW PREDICTS COMPLETE RESPONSE AND DRIVE EARLY SALVAGE CHEMOTHERAPY IN AML: RESULTS OF MULTIPARAMETER FLOW CYTOMETRY AND WT1-RNA QUANTIFICATION 39
POST-TRANSPLANT CYCLOPHOSPHAMIDE ELIMINATES MATURE DONOR NK CELLS, DAMPENING NATURAL KILLER CELL ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION 39
In vitro characterization of permissible HLA mismatches in allogeneic hematologic stem cell transplantation by use of autologous mixed lymphocyte reactions with retrovirally transduced CD40L-activated B cells 39
Choosing the Alternative 38
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T EMRA lymphocytes 38
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients 38
T-Cell Replete Haploidentical PBSC Transplantation Using Intensified Myeloablative Conditioning, Post-Transplant Cyclophosphamide and Sirolimus 38
Haploidentical HSCT: a 15-year experience at San Raffaele. 37
Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia 37
Totale 5.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.161
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021134 0 0 0 0 0 1 126 2 5 0 0 0
2021/2022144 0 0 0 34 12 8 6 21 22 18 10 13
2022/20231.263 493 293 82 10 43 136 38 79 49 14 17 9
2023/2024670 32 29 61 66 44 87 106 56 12 23 30 124
2024/20253.424 429 66 62 86 89 256 431 390 614 510 240 251
2025/20264.468 740 755 732 1.540 668 33 0 0 0 0 0 0
Totale 10.173